Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around?
Johnson & Johnson is normally a good buy for its dividend and the stability it offers. Over the past five years, however, the ...
Johnson & Johnson aims to sell Cerenovus for over $1 billion - Financial Times
Johnson & Johnson (NYSE:JNJ), the New Jersey-based healthcare company, is planning to sell its stroke care business, ...
Time on MSN9d
Why Johnson & Johnson’s CEO Welcomes Scrutiny
Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.
Is Johnson & Johnson Stock a Buy?
The healthcare leader is also an excellent income stock. Johnson & Johnson has increased its dividend payout for 62 ...
3JNJ : P/E Ratio Insights for Johnson & Johnson
Compared to the aggregate P/E ratio of the 27.1 in the Pharmaceuticals industry, Johnson & Johnson Inc. has a lower P/E ratio ...
Johnson & Johnson: NZ class action launched over cold and flu medicine product
The lawsuit says Kiwis have been deceived for about two decades about an ingredient in cold and flu medicine.
Irish Examiner on MSN5d
Johnson & Johnson Innovative Medicine named Cork Chamber Company of the Year
J&J IM, which this year marks two decades in Cork, was presented with the award at Cork Chamber’s annual dinner at City Hall ...
Hosted on MSN5d
Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know
Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...